They will argue it is cost saving if it can get patients out the hospital 5 days earlier...
Completely agree, @peterbachmd! $3120 per course seems like a lot of $$ to pay drug that doesn't save lives @gregggonsalves @jbkrell @PrEP4AllNow @akapczynski @ADPaltiel @RobbieForChange @GileadScienceshttps://twitter.com/peterbachmd/status/1316828634674585600 …
-
-
-
If
#COVID19 has proven one thing, its that ample use of a given drug does not necessarily stem from proven mortality (or indeed, any) benefit. There is, of course, value in getting out of hospital quicker. How much that is worth, I'll leave to others. I'd like to get it, however. - Näytä vastaukset
Uusi keskustelu -
-
-
The cost of a drug that doesn't work is $0. Why would you buy it?
$GILD -
I think this isn’t your standard “supply and demand rules” where pricing fluctuates according to competition. For all intensive purposes, these are monopoly powers and rules that have allowed this to go unchecked at this price tag.
Keskustelun loppu
Uusi keskustelu -
-
-
I saw you on
#CNN just now saying there was not strong evidence or data on Vitamin D helping with COVID. I disagree. Many people have low D and there also is evidence and some recent studies that shows D helps with COVID and upper respiratory infections. -
Synthetic D does not help much and cod liver oil is best.
Keskustelun loppu
Uusi keskustelu -
-
-
Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
-
-
It's outrageous.
@GileadSciences is a historically bad price-gouger, IP manipulating company. Won't let a pandemic slow them down.Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
-
-
Xigris redux.
Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
Lataaminen näyttää kestävän hetken.
Twitter saattaa olla ruuhkautunut tai ongelma on muuten hetkellinen. Yritä uudelleen tai käy Twitterin tilasivulla saadaksesi lisätietoja.